Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 242

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 242
---
 acquire any equity interest or other interest in any other person; |

| • | acquire, (i) by merging or consolidating with, or by purchasing all or a substantial portion of the assets or any stock of, or by any other manner, any business or any corporation, partnership, joint venture, limited liability company, association or other business organization or division thereof or (ii) any assets that are material, individually or in the aggregate, to LNHC and its subsidiaries, taken as a whole; |

| • | except in the ordinary course of business, sell, lease, license, pledge, or otherwise dispose of or encumber any properties or assets material to LNHC; |

| • | enter into any material transaction other than in the ordinary course of business; |

| • | license any material intellectual property to or from any third party; |

| • | initiate, threaten, compromise or settle any litigation or arbitration proceeding (other than any litigation to enforce its rights under the Merger Agreement); |

133

TABLE OF CONTENTS

| • | (i) incur or suffer to exist any indebtedness for borrowed money or guarantee any such indebtedness of another person in excess of $100,000 in the aggregate, (ii) issue, sell, or amend any debt securities or warrants or other rights to acquire any debt securities of LNHC, guarantee any debt securities of another person, enter into any “keep well” or other agreement to maintain any financial statement condition of another person, or enter into any arrangement having the economic effect of any of the foregoing, or (iii) make any loans, advances (other than routine advances to employees of LNHC in the ordinary course of business) or capital contributions to, or investment in, any other person; |

| • | create or otherwise incur any encumbrance on any material asset of LNHC or any of its subsidiaries, subject to exceptions; |

| • | incur, pay or otherwise agree to bear any transaction expenses in excess of $5,000,000; |

| • | forgive any loans to any person, including its employees, officers, directors or affiliate; |

| • | enter into any agreement to purchase or sell any interest in real property, grant any security interest in any real property, enter into any lease, sublease, license or other occupancy agreement with respect to any real property or alter, amend or modify any agreement that terminated any LNHC lease; |

| • | except in the ordinary course of business, make (i) any capital expenditures or